Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a Drosophila melanogaster Schneider 2 stable cell line system by Hjerrild, K, Jin, J, Wright, K, Brown, R, Marshall, J, Labbe, G, Silk, S, Cherry, C, Clemmensen, S, Jørgensen, T, Illingworth, J, Alanine, D, Milne, K, Ashfield, R, de Jongh, W, Douglas, A, Higgins, M, Draper, S

Accelerating the clinical development of protein-based vaccines for malaria by efficient purification using a four amino acid C-terminal 'C-tag'. by Jin, J, Hjerrild, K, Silk, S, Brown, R, Labbé, G, Marshall, J, Wright, K, Bezemer, S, Clemmensen, S, Biswas, S, Li, Y, El-Turabi, A, Douglas, A, Hermans, P, Detmers, F, de Jongh, W, Higgins, M, Ashfield, R, Draper, S

Safety and immunogenicity of the novel plasmodium falciparum blood-stage vaccine chad63-mva rh5 in a phase ia clinical trial by Payne, R, Silk, S, Elias, S, Miura, K, Diouf, A, Alanine, D, Jin, J, Labbe, G, Brian, I, Poulton, I, Griffiths, O, Edwards, N, Berrie, E, Siani, L, Douglas, A, Roberts, R, Vekemans, J, Nugent, F, Hill, A, Long, C, Lawrie, A, Draper, S

Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies by Payne, R, Silk, S, Elias, S, Milne, K, Rawlinson, T, Llewellyn, D, Shakri, A, Jin, J, Labbé, G, Edwards, N, Poulton, I, Roberts, R, Farid, R, Jørgensen, T, Alanine, D, de Cassan, S, Higgins, M, Otto, T, McCarthy, J, de Jongh, W, Nicosia, A, Moyle, S, Hill, A, Berrie, E, Chitnis, C, Lawrie, A, Draper, S

Demonstration of the blood-stage controlled human malaria infection model to assess efficacy of the Plasmodium falciparum AMA1 vaccine FMP2.1/AS01 by Payne, R, Milne, K, Elias, S, Edwards, N, Douglas, A, Brown, R, Silk, S, Biswas, S, Miura, K, Roberts, R, Rampling, T, Venkatraman, N, Hodgson, S, Labbé, G, Halstead, F, Poulton, I, Nugent, F, de Graaf, H, Sukhtankar, P, Williams, N, Ockenhouse, C, Kathcart, A, Qabar, A, Waters, N, Soisson, L, Birkett, A, Cooke, G, Faust, S, Woods, C, Ivinson, K, McCarthy, J, Diggs, C, Vekemans, J, Long, C, Hill, A, Lawrie, A, Dutta, S, Draper, S

A monovalent chimpanzee adenovirus ebola vaccine boosted with MVA by Ewer (nee Russell), K, Rampling, T, Venkatraman, N, Bowyer, G, Wright, D, Lambe, T, Imoukhuede, E, Payne, R, Fehling, S, Strecker, T, Biedenkopf, N, Krähling, V, Tully, C, Edwards, N, Bentley, E, Samuel, D, Labbe, G, Jin, J, Gibani, M, Minhinnick, A, Wilkie, M, Poulton, I, Lella, N, Roberts, R, Hartnell, F, Bliss, C, Sierra-Davidson, K, Powlson, J, Berrie, E, Tedder, R, Roman, F, Ryck, I, Nicosia, A, Sullivan, N, Stanley, D, Mbaya, O, Ledgerwood, J, Schwartz, R, Siani, L, Colloca, S, Folgori, A, Di Marco, S, Cortese, R, Wright, E, Becker, S, Graham, B, Koup, R, Levine, M, Volkmann, A, Chaplin, P, Pollard, A, Draper, S, Ballou, W, Lawrie, A, Gilbert, S, Hill, A